A cellular regulator of the niche: telocyte

References

• Rosa I, Ibba-Manneschi L, Guasti D, Perigli G, Faussone-Pellegrini MS, Manetti M. Morphologic evidence of telocytes in human thyroid stromal tissue. J Cell Mol Med. 2022;26(8):312–331. doi:10.1111/jcmm.17282.
   PubMed Web of Science ®Google Scholar
• Vannucchi MG. The telocytes: ten years after their introduction in the scientific literature. An update on their morphology, distribution, and potential roles in the gut. Int J Mol Sci. 2020;21(12):4478. doi:10.3390/ijms21124478.
   PubMed Web of Science ®Google Scholar
• Nie ZY, Zhao MH, Cheng BQ, Pan RF, Wang TR, Qin Y, Zhang XJ. Tanshinone IIA regulates human AML cell proliferation, cell cycle, and apoptosis through miR-497-5p/AKT3 axis. Cancer Cell Int. 2020;20(1):379. doi:10.1186/s12935-020-01468-5.
   PubMed Web of Science ®Google Scholar
• Rosa I, Marini M, Manetti M. Telocytes: an emerging component of stem cell niche microenvironment. J Histochem Cytochem. 2021;69(12):795–818. doi:10.1369/00221554211025489.
   PubMed Web of Science ®Google Scholar
• Maldarine JS, Sanches BDA, Santos VA, Goes RM, Vilamaior PSL, Carvalho HF, Taboga SR. The complex role of telocytes in female prostate tumorigenesis in a rodent model. Cell Biol Int. 2022;46(9):1495–1509. doi:10.1002/cbin.11816.
   PubMed Web of Science ®Google Scholar
• Kostin S. Myocardial telocytes: a specific new cellular entity. J Cell Mol Med. 2010;14(7):1917–1921. doi:10.1111/j.1582-4934.2010.01111.x.
   PubMed Web of Science ®Google Scholar
• Thuneberg L. One hundred years of interstitial cells of Cajal. Microsc Res Tech. 1999;47(4):223–238. doi:10.1002/(SICI)1097-0029(19991115)47:4<223::AID-JEMT2>3.0.CO;2-C.
   PubMed Web of Science ®Google Scholar
• Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology. 1996;111(2):492–515. doi:10.1053/gast.1996.v111.pm8690216.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Faussone-Pellegrini MS. TELOCYTES - a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010;14(4):729–740. doi:10.1111/j.1582-4934.2010.01059.x.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Gherghiceanu M, Cretoiu D, Radu E. The connective connection: interstitial cells of Cajal (ICC) and ICC-like cells establish synapses with immunoreactive cells. Electron microscope study in situ. J Cell Mol Med. 2005;9(3):714–730. doi:10.1111/j.1582-4934.2005.tb00502.x.
   PubMed Web of Science ®Google Scholar
• Cretoiu SM, Popescu LM. Telocytes revisited. Biomol Concepts. 2014;5(5):353–369. doi:10.1515/bmc-2014-0029.
   PubMedGoogle Scholar
• Yang P, Zhu X, Wang L, Ahmed N, Huang Y, Chen H, Zhang Q, Ullah S, Liu T, Guo D, et al. Cellular evidence of telocytes as novel interstitial cells within the magnum of chicken oviduct. Cell Transplant. 2017;26(1):135–143. doi:10.3727/096368916X692942.
   PubMed Web of Science ®Google Scholar
• Fu S, Zhu H, Li S, Wang Y, Bei Y, Xiao J. Telocytes in cardiac protection. Curr Stem Cell Res Ther. 2016;11(5):390–394. doi:10.2174/1574888X1105160509234231.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wang X. Roles of telocytes in the development of angiogenesis. Adv Exp Med Biol. 2016;913:253–261.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Ciontea SM, Cretoiu D. Interstitial Cajal-like cells in human uterus and fallopian tube. Ann N Y Acad Sci. 2007;1101(1):139–165. doi:10.1196/annals.1389.022.
   PubMedGoogle Scholar
• Popescu L. [Remembering academician Prof. Dr Nicolae Cajal–excerpts from speeches celebrating the 90 anniversary of his birth (1919-2004)]. Bacteriol Virusol Parazitol Epidemiol. 2009;54:185–195.
   PubMedGoogle Scholar
• Roatesi I, Radu BM, Cretoiu D, Cretoiu SM. Uterine telocytes: a review of current knowledge. Biol Reprod. 2015;93(1):10. doi:10.1095/biolreprod.114.125906.
   PubMed Web of Science ®Google Scholar
• Song D, Cretoiu D, Cretoiu SM, Wang X. Telocytes and lung disease. Histol Histopathol. 2016;31(12):1303–1314. doi:10.14670/HH-11-807.
   PubMed Web of Science ®Google Scholar
• Cretoiu D, Hummel E, Zimmermann H, Gherghiceanu M, Popescu LM. Human cardiac telocytes: 3D imaging by FIB-SEM tomography. J Cell Mol Med. 2014;18(11):2157–2164. doi:10.1111/jcmm.12468.
   PubMed Web of Science ®Google Scholar
• Gherghiceanu M, Hinescu ME, Andrei F, Mandache E, Macarie CE, Faussone-Pellegrini MS, Popescu LM. Interstitial Cajal-like cells (ICLC) in myocardial sleeves of human pulmonary veins. J Cell Mol Med. 2008;12(5A):1777–1781. doi:10.1111/j.1582-4934.2008.00444.x.
   PubMed Web of Science ®Google Scholar
• Gherghiceanu M, Popescu LM. Interstitial Cajal-like cells (ICLC) in human resting mammary gland stroma. Transmission electron microscope (TEM) identification. J Cell Mol Med. 2005;9(4):893–910. doi:10.1111/j.1582-4934.2005.tb00387.x.
   PubMed Web of Science ®Google Scholar
• Hinescu ME, Popescu LM, Gherghiceanu M, Faussone-Pellegrini MS. Interstitial Cajal-like cells in rat mesentery: an ultrastructural and immunohistochemical approach. J Cell Mol Med. 2008;12(1):260–270. doi:10.1111/j.1582-4934.2008.00226.x.
   PubMed Web of Science ®Google Scholar
• Kostin S, Popescu LM. A distinct type of cell in myocardium: interstitial Cajal-like cells (ICLCs). J Cell Mol Med. 2009;13(2):295–308. doi:10.1111/j.1582-4934.2008.00668.x.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Gherghiceanu M, Hinescu ME, Cretoiu D, Ceafalan L, Regalia T, Popescu AC, Ardeleanu C, Mandache E. Insights into the interstitium of ventricular myocardium: interstitial Cajal-like cells (ICLC). J Cell Mol Med. 2006;10(2):429–458. doi:10.1111/j.1582-4934.2006.tb00410.x.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Gherghiceanu M, Manole CG, Faussone-Pellegrini MS. Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med. 2009;13(5):866–886. doi:10.1111/j.1582-4934.2009.00758.x.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Bai C, Wang X. Potential significance of telocytes in the pathogenesis of lung diseases. Expert Rev Respir Med. 2012;6(1):45–49. doi:10.1586/ers.11.91.
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun W, Wu SM, Xiao J, Kong X. Telocytes in human heart valves. J Cell Mol Med. 2014;18(5):759–765. doi:10.1111/jcmm.12285.
   PubMed Web of Science ®Google Scholar
• Rusu MC, Jianu AM, Mirancea N, Didilescu AC, Manoiu VS, Paduraru D. Tracheal telocytes. J Cell Mol Med. 2012;16(2):401–405. doi:10.1111/j.1582-4934.2011.01465.x.
   PubMed Web of Science ®Google Scholar
• Zhang HQ, Lu SS, Xu T, Feng YL, Li H, Ge JB. Morphological evidence of telocytes in mice aorta. Chin Med J (Engl). 2015;128(3):348–352. doi:10.4103/0366-6999.150102.
   PubMed Web of Science ®Google Scholar
• Chen X, Zheng Y, Manole CG, Wang X, Wang Q. Telocytes in human oesophagus. J Cell Mol Med. 2013;17(11):1506–1512. doi:10.1111/jcmm.12149.
   PubMed Web of Science ®Google Scholar
• Vannucchi MG, Traini C, Manetti M, Ibba-Manneschi L, Faussone-Pellegrini MS. Telocytes express PDGFRalpha in the human gastrointestinal tract. J Cell Mol Med. 2013;17(9):1099–1108. doi:10.1111/jcmm.12134.
   PubMed Web of Science ®Google Scholar
• Cretoiu SM. Telocytes in focus. Semin Cell Dev Biol. 2016;55:1–2. doi:10.1016/j.semcdb.2016.05.019.
   PubMed Web of Science ®Google Scholar
• Shoshkes-Carmel M, Wang YJ, Wangensteen KJ, Toth B, Kondo A, Massasa EE, Itzkovitz S, Kaestner KH. Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature. 2018;557(7704):242–246. doi:10.1038/s41586-018-0084-4.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Hinescu ME, Ionescu N, Ciontea SM, Cretoiu D, Ardelean C. Interstitial cells of Cajal in pancreas. J Cell Mol Med. 2005;9(1):169–190. doi:10.1111/j.1582-4934.2005.tb00347.x.
   PubMed Web of Science ®Google Scholar
• Hinescu ME, Ardeleanu C, Gherghiceanu M, Popescu LM. Interstitial Cajal-like cells in human gallbladder. J Mol Histol. 2007;38(4):275–284. doi:10.1007/s10735-007-9099-0.
   PubMed Web of Science ®Google Scholar
• Nicolescu MI, Bucur A, Dinca O, Rusu MC, Popescu LM. Telocytes in parotid glands. Anat Rec (Hoboken). 2012;295(3):378–385. doi:10.1002/ar.21540.
   PubMedGoogle Scholar
• Qi G, Lin M, Xu M, Manole CG, Wang X, Zhu T. Telocytes in the human kidney cortex. J Cell Mol Med. 2012;16(12):3116–3122. doi:10.1111/j.1582-4934.2012.01582.x.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhu T, Lin M, Wu D, Wang X. Telocytes in the urinary system. J Transl Med. 2012;10(1):188. doi:10.1186/1479-5876-10-188.
   PubMedGoogle Scholar
• Vannucchi MG, Traini C. Interstitial cells of Cajal and telocytes in the gut: twins, related or simply neighbor cells? Biomol Concepts. 2016;7(2):93–102. doi:10.1515/bmc-2015-0034.
   PubMedGoogle Scholar
• Suciu L, Popescu LM, Gherghiceanu M, Regalia T, Nicolescu MI, Hinescu ME, Faussone-Pellegrini MS. Telocytes in human term placenta: morphology and phenotype. Cells Tissues Organs. 2010;192(5):325–339. doi:10.1159/000319467.
   PubMed Web of Science ®Google Scholar
• Cretoiu SM, Cretoiu D, Popescu LM. Human myometrium - the ultrastructural 3D network of telocytes. J Cell Mol Med. 2012;16(11):2844–2849. doi:10.1111/j.1582-4934.2012.01651.x.
   PubMed Web of Science ®Google Scholar
• Cretoiu SM, Cretoiu D, Marin A, Radu BM, Popescu LM. Telocytes: ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction. 2013;145(4):357–370. doi:10.1530/REP-12-0369.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang H, Yang L, Lu S, Ge J. Telocytes in mice bone marrow: electron microscope evidence. J Cell Mol Med. 2014;18(6):975–978. doi:10.1111/jcmm.12337.
   PubMed Web of Science ®Google Scholar
• Petre N, Rusu MC, Pop F, Jianu AM. Telocytes of the mammary gland stroma. Folia Morphol (Warsz). 2016;75(2):224–231. doi:10.5603/FM.a2015.0123.
   PubMed Web of Science ®Google Scholar
• Chang Y, Li C, Gan L, Li H, Guo Z, Aikawa E. Telocytes in the Spleen. PLoS One. 2015;10(9):e0138851. doi:10.1371/journal.pone.0138851.
   PubMed Web of Science ®Google Scholar
• Rusu MC, Mirancea N, Manoiu VS, Valcu M, Nicolescu MI, Paduraru D. Skin telocytes. Ann Anat. 2012;194(4):359–367. doi:10.1016/j.aanat.2011.11.007.
   PubMed Web of Science ®Google Scholar
• Ceafalan L, Gherghiceanu M, Popescu LM, Simionescu O. Telocytes in human skin–are they involved in skin regeneration? J Cell Mol Med. 2012;16(7):1405–1420. doi:10.1111/j.1582-4934.2012.01580.x.
   PubMed Web of Science ®Google Scholar
• Corradi LS, Jesus MM, Fochi RA, Vilamaior PS, Justulin LA Jr., Goes RM, Felisbino SL, Taboga SR. Structural and ultrastructural evidence for telocytes in prostate stroma. J Cell Mol Med. 2013;17(3):398–406. doi:10.1111/jcmm.12021.
   PubMed Web of Science ®Google Scholar
• Aleksandrovych V, Pasternak A, Basta P, Sajewicz M, Walocha JA, Gil K. Telocytes: facts, speculations and myths (Review article). Folia Med Cracov. 2017;57:5–22.
   PubMedGoogle Scholar
• Edelstein L, Fuxe K, Levin M, Popescu BO, Smythies J. Telocytes in their context with other intercellular communication agents. Semin Cell Dev Biol. 2016;55:9–13. doi:10.1016/j.semcdb.2016.03.010.
   PubMed Web of Science ®Google Scholar
• Edelstein L, Smythies J. Epigenetic aspects of telocytes/cordocytes: jacks of all trades, masters of most. Front Cell Neurosci. 2014;8:32. doi:10.3389/fncel.2014.00032.
   PubMed Web of Science ®Google Scholar
• Tang L, Song D, Qi R, Zhu B, Wang X. Roles of pulmonary telocytes in airway epithelia to benefit experimental acute lung injury through production of telocyte-driven mediators and exosomes. Cell Biol Toxicol. 2022. doi:10.1007/s10565-021-09670-5.
   Web of Science ®Google Scholar
• Xue Y, Schmollinger S, Attar N, Campos OA, Vogelauer M, Carey MF, Merchant SS, Kurdistani SK. Endoplasmic reticulum-mitochondria junction is required for iron homeostasis. J Biol Chem. 2017;292(32):13197–13204. doi:10.1074/jbc.M117.784249.
   PubMed Web of Science ®Google Scholar
• Manetti M, Guiducci S, Ruffo M, Rosa I, Faussone-Pellegrini MS, Matucci-Cerinic M, Ibba-Manneschi L. Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J Cell Mol Med. 2013;17(4):482–496. doi:10.1111/jcmm.12028.
   PubMed Web of Science ®Google Scholar
• Ye L, Song D, Jin M, Wang X. Therapeutic roles of telocytes in OVA-induced acute asthma in mice. J Cell Mol Med. 2017;21(11):2863–2871. doi:10.1111/jcmm.13199.
   PubMed Web of Science ®Google Scholar
• Liao Z, Chen Y, Duan C, Zhu K, Huang R, Zhao H, Hintze M, Pu Q, Yuan Z, Lv L, et al. Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. Theranostics. 2021;11(1):268–291. doi:10.7150/thno.47021.
   PubMed Web of Science ®Google Scholar
• Cucu I, Nicolescu MI, Busnatu SS, Manole CG. Dynamic involvement of telocytes in modulating multiple signaling pathways in cardiac cytoarchitecture. Int J Mol Sci. 2022;23(10):10. doi:10.3390/ijms23105769.
   Web of Science ®Google Scholar
• Smalheiser NR. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct. 2007;2(1):35. doi:10.1186/1745-6150-2-35.
   PubMedGoogle Scholar
• Albulescu R, Tanase C, Codrici E, Popescu DI, Cretoiu SM, Popescu LM. The secretome of myocardial telocytes modulates the activity of cardiac stem cells. J Cell Mol Med. 2015;19(8):1783–1794. doi:10.1111/jcmm.12624.
   PubMed Web of Science ®Google Scholar
• Cismasiu VB, Popescu LM. Telocytes transfer extracellular vesicles loaded with microRNAs to stem cells. J Cell Mol Med. 2015;19(2):351–358. doi:10.1111/jcmm.12529.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang Y, Liang T, Hu Y, Tang H, Song D, Fang H. The regulatory effect of microRNA-21a-3p on the promotion of telocyte angiogenesis mediated by PI3K (p110alpha)/AKT/mTOR in LPS induced mice ARDS. J Transl Med. 2019;17(1):427. doi:10.1186/s12967-019-02168-z.
   PubMed Web of Science ®Google Scholar
• Tang H, Liang T, Zhou Y, Ju H, Song D, Fang H. Telocytes reduce oxidative stress by downregulating DUOX2 expression in inflamed lungs of mice. Acta Biochim Biophys Sin (Shanghai). 2022;54(4):574–582. doi:10.3724/abbs.2022017.
   PubMed Web of Science ®Google Scholar
• Xu Y, Tian H, Luan CG, Sun K, Bao PJ, Zhang HY, Zhang N. Telocytes promote hepatocellular carcinoma by activating the ERK signaling pathway and miR-942-3p/MMP9 axis. Cell Death Discov. 2021;7(1):209. doi:10.1038/s41420-021-00592-z.
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682–688. doi:10.1038/nature06174.
   PubMed Web of Science ®Google Scholar
• Bu J, Li H, Li XY, Liu LH, Sun W, Xiao T. Prognostic role of microRNA-126 for survival in malignant tumors: a systematic review and meta-analysis. Dis Markers. 2015;2015:739469. doi:10.1155/2015/739469.
   PubMed Web of Science ®Google Scholar
• van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med. 2009;13(8A):1577–1585. doi:10.1111/j.1582-4934.2008.00613.x.
   PubMed Web of Science ®Google Scholar
• Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261–271. doi:10.1016/j.devcel.2008.07.002.
   PubMed Web of Science ®Google Scholar
• Aschacher T, Aschacher O, Schmidt K, Enzmann FK, Eichmair E, Winkler B, Arnold Z, Nagel F, Podesser BK, Mitterbauer A, et al. The role of telocytes and telocyte-derived exosomes in the development of thoracic aortic aneurysm. Int J Mol Sci. 2022;23(9):4730. doi:10.3390/ijms23094730.
   PubMed Web of Science ®Google Scholar
• Bei Y, Wang F, Yang C, Xiao J. Telocytes in regenerative medicine. J Cell Mol Med. 2015;19(7):1441–1454. doi:10.1111/jcmm.12594.
   PubMed Web of Science ®Google Scholar
• Yang R, Tang Y, Chen X, Yang Y. Telocytes-derived extracellular vesicles alleviate aortic valve calcification by carrying miR-30b. ESC Heart Fail. 2021;8(5):3935–3946. doi:10.1002/ehf2.13460.
   PubMed Web of Science ®Google Scholar
• Fertig ET, Gherghiceanu M, Popescu LM. Extracellular vesicles release by cardiac telocytes: electron microscopy and electron tomography. J Cell Mol Med. 2014;18(10):1938–1943. doi:10.1111/jcmm.12436.
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Ratajczak J. Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later. Clin Transl Med. 2016;5(1):7. doi:10.1186/s40169-016-0087-4.
   PubMedGoogle Scholar
• Li Y, Zhang X, Gao J, Xiao H, Xu M. Increased telocytes involved in the proliferation of vascular smooth muscle cells in rat carotid artery balloon injury. Sci China Life Sci. 2016;59(7):678–685. doi:10.1007/s11427-016-5075-9.
   PubMed Web of Science ®Google Scholar
• Aschacher T, Schmidt K, Aschacher O, Eichmair E, Baranyi U, Winkler B, Grabenwoeger M, Spittler A, Enzmann F, Messner B, et al. Telocytes in the human ascending aorta: characterization and exosome-related KLF-4/VEGF-A expression. J Cell Mol Med. 2021;25(20):9697–9709. doi:10.1111/jcmm.16919.
   PubMed Web of Science ®Google Scholar
• Yao Q, Chen Y, Zhou X. The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol. 2019;51:11–17. doi:10.1016/j.cbpa.2019.01.024.
   PubMed Web of Science ®Google Scholar
• Yan J, Ma S, Zhang Y, Yin C, Zhou X, Zhang G. Potential role of microRNA-126 in the diagnosis of cancers: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(35):e4644. doi:10.1097/MD.0000000000004644.
   PubMed Web of Science ®Google Scholar
• Yan T, Cui K, Huang X, Ding S, Zheng Y, Luo Q, Liu X, Zou L. Assessment of therapeutic efficacy of miR-126 with contrast-enhanced ultrasound in preeclampsia rats. Placenta. 2014;35(1):23–29. doi:10.1016/j.placenta.2013.10.017.
   PubMed Web of Science ®Google Scholar
• Meister J, Schmidt MH. H. miR-126 and miR-126*: new players in cancer. ScientificWorldJournal. 2010;10:2090–2100. doi:10.1100/tsw.2010.198.
   PubMedGoogle Scholar
• Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15(2):272–284. doi:10.1016/j.devcel.2008.07.008.
   PubMed Web of Science ®Google Scholar
• Zhao D, Shao H. Effect of blood purification on serum miR-126 and VEGF levels in the process of atherosclerosis in uremic patients under maintenance hemodialysis. Kaohsiung J Med Sci. 2018;34(8):447–455. doi:10.1016/j.kjms.2018.04.004.
   PubMed Web of Science ®Google Scholar
• Li P, Wei J, Li X, Cheng Y, Chen W, Cui Y, Simoncini T, Gu Z, Yang J, Fu X. 17beta-estradiol enhances vascular endothelial Ets-1/miR-126-3p expression: the possible mechanism for attenuation of atherosclerosis. J Clin Endocrinol Metab. 2017;102(2):594–603. doi:10.1210/jc.2016-2974.
   PubMed Web of Science ®Google Scholar
• Hao XZ, Fan HM. Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway. Eur Rev Med Pharmacol Sci. 2017;21:2725–2733.
   PubMed Web of Science ®Google Scholar
• Lei H, Li H, Tian L, Li M, Xin Z, Zhang X, Guan R. Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells. Drug Des Devel Ther. 2018;12:1743–1751. doi:10.2147/DDDT.S166734.
   PubMed Web of Science ®Google Scholar
• Li N, Li X, Huang S, Shen S, Wang X. miR-126 inhibits colon cancer proliferation and invasion through targeting IRS1, SLC7A5 and TOM1 gene. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013;38(8):809–817. doi:10.3969/j.1672-7347.2013.08.009.
   PubMedGoogle Scholar
• Huang W, Lin J, Zhang H. miR-126: a novel regulator in colon cancer. Biomed Rep. 2016;4(2):131–134. doi:10.3892/br.2015.549.
   PubMedGoogle Scholar
• Ma R, Wu P, Shi Q, Song D, Fang H. Telocytes promote VEGF expression and alleviate ventilator-induced lung injury in mice. Acta Biochim Biophys Sin (Shanghai). 2018;50(8):817–825. doi:10.1093/abbs/gmy066.
   PubMed Web of Science ®Google Scholar
• Soofiyani SR, Hosseini K, Ebrahimi T, Frohandeh H, Sadeghi M, Beirami SM, Ghasemnejad T, Tarhriz V, Montazersaheb S. Prognostic value and biological role of miR-126 in breast cancer. Microrna. 2022;11. doi:10.2174/1876402914666220428123203.
   PubMedGoogle Scholar
• Monaco F, Gaetani S, Alessandrini F, Tagliabracci A, Bracci M, Valentino M, Neuzil J, Amati M, Bovenzi M, Tomasetti M, et al. Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: role of miR-126 in cancer-stroma communication. Cancer Lett. 2019;463:27–36. doi:10.1016/j.canlet.2019.08.001.
   PubMed Web of Science ®Google Scholar
• Kong R, Ma Y, Feng J, Li S, Zhang W, Jiang J, Zhang J, Qiao Z, Yang X, Zhou B. The crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A. Cell Mol Biol Lett. 2016;21(1):3. doi:10.1186/s11658-016-0004-2.
   PubMedGoogle Scholar
• Tehler D, Hoyland-Kroghsbo NM, Lund AH. The miR-10 microRNA precursor family. RNA Biol. 2011;8(5):728–734. doi:10.4161/rna.8.5.16324.
   PubMed Web of Science ®Google Scholar
• Zhi Y, Xie X, Wang R, Wang B, Gu W, Ling Y, Dong W, Zhi F, Liu Y. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia. Int J Hematol. 2015;102(3):296–303. doi:10.1007/s12185-015-1829-6.
   PubMed Web of Science ®Google Scholar
• Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O’Sullivan B, Waldron J, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 2010;16(4):1129–1139. doi:10.1158/1078-0432.CCR-09-2166.
   PubMed Web of Science ®Google Scholar
• Hammou RA, Kasmi Y, Ennaji MM. A computational approach to the study of interactions between proteins and miR10-b, miR-335, and miR-21 involved in breast cancer. Contemp Oncol (Pozn). 2019;23(4):220–225. doi:10.5114/wo.2019.91544.
   PubMed Web of Science ®Google Scholar
• Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem. 2010;285(11):7986–7994. doi:10.1074/jbc.M109.062877.
   PubMed Web of Science ®Google Scholar
• Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta. 2009;1792(6):497–505. doi:10.1016/j.bbadis.2009.02.013.
   PubMed Web of Science ®Google Scholar
• Zanoaga O, Braicu C, Chiroi P, Andreea N, Hajjar NA, Margarit S, Korban SS, Berindan-Neagoe I. The role of miR-155 in nutrition: modulating cancer-associated inflammation. Nutrients. 2021;13(7):2245. doi:10.3390/nu13072245.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu J. Role of miR-155 in breast cancer. Front Biosci (Landmark Ed). 2012;17(6):2350–2355. doi:10.2741/4056.
   PubMedGoogle Scholar
• Mattiske S, Suetani RJ, Neilsen PM, Callen DF. The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol Biomarkers Prev. 2012;21(8):1236–1243. doi:10.1158/1055-9965.EPI-12-0173.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang T, Zhou X, Du Z, Chen F, Luo J, Liu Q. The tumor suppressor role of miR-155-5p in gastric cancer. Oncol Lett. 2018;16(2):2709–2714. doi:10.3892/ol.2018.8932.
   PubMed Web of Science ®Google Scholar
• Guo T, Wang XX, Fu H, Tang YC, Meng BQ, Chen CH. Early diagnostic role of PSA combined miR-155 detection in prostate cancer. Eur Rev Med Pharmacol Sci. 2018;22(6):1615–1621. doi:10.26355/eurrev_201803_14568.
   PubMed Web of Science ®Google Scholar
• Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res. 2007;67(22):10782–10788. doi:10.1158/0008-5472.CAN-07-1484.
   PubMed Web of Science ®Google Scholar
• Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A. 2007;104(41):16170–16175. doi:10.1073/pnas.0703942104.
   PubMed Web of Science ®Google Scholar
• Ding H, Wang Y, Hu L, Xue S, Wang Y, Zhang L, Zhang Y, Qi H, Yu H, Aung LHH, et al. Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases. Biosci Rep. 2020;40(3):3. doi:10.1042/BSR20191653.
   Google Scholar
• Stankovic A, Kolakovic A, Zivkovic M, Djuric T, Bundalo M, Koncar I, Davidovic L, Alavantic D. Angiotensin receptor type 1 polymorphism A1166C is associated with altered AT1R and miR-155 expression in carotid plaque tissue and development of hypoechoic carotid plaques. Atherosclerosis. 2016;248:132–139. doi:10.1016/j.atherosclerosis.2016.02.032.
   PubMed Web of Science ®Google Scholar
• Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, Fabricio AS, Squarcina E, Gion M, Palatini P, et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens. 2011;24(2):241–246. doi:10.1038/ajh.2010.211.
   PubMed Web of Science ®Google Scholar
• He Y, Cai Y, Pai PM, Ren X, Xia Z. The causes and consequences of miR-503 dysregulation and its impact on cardiovascular disease and cancer. Front Pharmacol. 2021;12:629611. doi:10.3389/fphar.2021.629611.
   PubMed Web of Science ®Google Scholar
• Hirakawa T, Nasu K, Abe W, Aoyagi Y, Okamoto M, Kai K, Takebayashi K, Narahara H. miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells. Hum Reprod. 2016;31(11):2587–2597. doi:10.1093/humrep/dew217.
   PubMed Web of Science ®Google Scholar
• Zhou B, Ma R, Si W, Li S, Xu Y, Tu X, Wang Q. MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. Cancer Lett. 2013;333(2):159–169. doi:10.1016/j.canlet.2013.01.028.
   PubMed Web of Science ®Google Scholar
• Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, et al. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. J Transl Med. 2013;11(1):195. doi:10.1186/1479-5876-11-195.
   PubMedGoogle Scholar
• Zhang Y, Chen X, Lian H, Liu J, Zhou B, Han S, Peng B, Yin J, Liu W, He X. MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R. Oncol Rep. 2014;31(3):1445–1452. doi:10.3892/or.2013.2951.
   PubMed Web of Science ®Google Scholar
• Li C, Gao Y, Zhang K, Chen J, Han S, Feng B, Wang R, Chen L. Multiple roles of MicroRNA-100 in human cancer and its therapeutic potential. Cell Physiol Biochem. 2015;37(6):2143–2159. doi:10.1159/000438572.
   PubMedGoogle Scholar
• Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo XQ, Zeng CW, Lin KY, Zhou H, Qu LH, Zhang P, et al. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene. 2012;31(1):80–92. doi:10.1038/onc.2011.208.
   PubMed Web of Science ®Google Scholar
• Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sanudo A, Antunes AA, Srougi M. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol. 2011;29(3):265–269. doi:10.1016/j.urolonc.2009.02.002.
   PubMed Web of Science ®Google Scholar
• Ye Y, Li SL, Wang J. J. miR-100-5p downregulates mTOR to suppress the proliferation, migration, and invasion of prostate cancer cells. Front Oncol. 2020;10:578948. doi:10.3389/fonc.2020.578948.
   PubMed Web of Science ®Google Scholar
• Leite KR, Morais DR, Reis ST, Viana N, Moura C, Florez MG, Silva IA, Dip N, Srougi M. MicroRNA 100: a context dependent miRNA in prostate cancer. Clinics (Sao Paulo). 2013;68(6):797–802. doi:10.6061/clinics/2013(06)12.
   PubMed Web of Science ®Google Scholar
• Qiu YH, Wei YP, Shen NJ, Wang ZC, Kan T, Yu WL, Yi B, Zhang Y. J. miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells. Cell Physiol Biochem. 2013;32(5):1331–1341. doi:10.1159/000354531.
   PubMed Web of Science ®Google Scholar
• Wang M, Ren D, Guo W, Wang Z, Huang S, Du H, Song L, Peng X. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. Int J Oncol. 2014;45(1):362–372. doi:10.3892/ijo.2014.2413.
   PubMed Web of Science ®Google Scholar
• Shimamura T, Imoto S, Shimada Y, Hosono Y, Niida A, Nagasaki M, Yamaguchi R, Takahashi T, Miyano S, Bernhard EJ. A novel network profiling analysis reveals system changes in epithelial-mesenchymal transition. PLoS One. 2011;6(6):e20804. doi:10.1371/journal.pone.0020804.
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Yu C, Wang M, Peng F, Xiao J, Tian R, Jiang J, Sun C. MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3. Tumour Biol. 2014;35(12):11751–11759. doi:10.1007/s13277-014-2271-8.
   PubMedGoogle Scholar
• Zhao W, Zhao SP, Zhao YH. MicroRNA-143/-145 in cardiovascular diseases. Biomed Res Int. 2015;2015:531740. doi:10.1155/2015/531740.
   PubMed Web of Science ®Google Scholar
• Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, et al. The knockout of miR-143 and −145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009;16(12):1590–1598. doi:10.1038/cdd.2009.153.
   PubMed Web of Science ®Google Scholar
• Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460(7256):705–710. doi:10.1038/nature08195.
   PubMed Web of Science ®Google Scholar
• Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest. 2009;119(9):2634–2647. doi:10.1172/JCI38864.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009;105(2):158–166. doi:10.1161/CIRCRESAHA.109.197517.
   PubMed Web of Science ®Google Scholar
• Li R, Yan G, Zhang Q, Jiang Y, Sun H, Hu Y, Sun J, Xu B. miR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA6. FEBS Lett. 2013;587(12):1754–1761. doi:10.1016/j.febslet.2013.04.018.
   PubMed Web of Science ®Google Scholar
• Blumensatt M, Greulich S, Herzfeld de Wiza D, Mueller H, Maxhera B, Rabelink MJ, Hoeben RC, Akhyari P, Al-Hasani H, Ruige JB, et al. Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143. Cardiovasc Res. 2013;100(2):201–210. doi:10.1093/cvr/cvt173.
   PubMed Web of Science ®Google Scholar
• Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE. Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens. 2014;28(8):510–516. doi:10.1038/jhh.2013.117.
   PubMed Web of Science ®Google Scholar
• D’Alessandra Y, Carena MC, Spazzafumo L, Martinelli F, Bassetti B, Devanna P, Rubino M, Marenzi G, Colombo GI, Achilli F, et al. Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PLoS One. 2013;8(11):e80345. doi:10.1371/journal.pone.0080345.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107(5):677–684. doi:10.1161/CIRCRESAHA.109.215566.
   PubMed Web of Science ®Google Scholar
• Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J, Leidinger P, et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol. 2011;106(1):13–23. doi:10.1007/s00395-010-0123-2.
   PubMed Web of Science ®Google Scholar
• Ma X, Conklin DJ, Li F, Dai Z, Hua X, Li Y, Xu-Monette ZY, Young KH, Xiong W, Wysoczynski M, et al. The oncogenic microRNA miR-21 promotes regulated necrosis in mice. Nat Commun. 2015;6(1):7151. doi:10.1038/ncomms8151.
   PubMedGoogle Scholar
• Zhao J, Zhang Y, Zhao G. Emerging role of microRNA-21 in colorectal cancer. Cancer Biomark. 2015;15(3):219–226. doi:10.3233/CBM-150468.
   PubMed Web of Science ®Google Scholar
• Feng YH, Tsao CJ. Emerging role of microRNA-21 in cancer. Biomed Rep. 2016;5(4):395–402. doi:10.3892/br.2016.747.
   PubMed Web of Science ®Google Scholar
• Sheedy FJ. Turning 21: induction of miR-21 as a key switch in the inflammatory response. Front Immunol. 2015;6:19. doi:10.3389/fimmu.2015.00019.
   PubMed Web of Science ®Google Scholar
• Zhou S, Sun Y, Zhao K, Gao Y, Cui J, Qi L, Huang L. miR21/PTEN pathway mediates the cardioprotection of geniposide against oxidized lowdensity lipoproteininduced endothelial injury via suppressing oxidative stress and inflammatory response. Int J Mol Med. 2020;45(5):1305–1316. doi:10.3892/ijmm.2020.4520.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xie J, Jiang F, Li Y, Chang G, Ma H. Inhibition of miR21 promotes cell apoptosis in oral squamous cell carcinoma by upregulating PTEN. Oncol Rep. 2018;40(5):2798–2805. doi:10.3892/or.2018.6663.
   PubMed Web of Science ®Google Scholar
• Wu H, Ng R, Chen X, Steer CJ, Song G. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway. Gut. 2016;65(11):1850–1860. doi:10.1136/gutjnl-2014-308430.
   PubMed Web of Science ®Google Scholar
• Bahreyni A, Rezaei M, Bahrami A, Khazaei M, Fiuji H, Ryzhikov M, Ferns GA, Avan A, Hassanian SM. Diagnostic, prognostic, and therapeutic potency of microRNA 21 in the pathogenesis of colon cancer, current status and prospective. J Cell Physiol. 2019;234(6):8075–8081. doi:10.1002/jcp.27580.
   PubMed Web of Science ®Google Scholar
• Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18(3):282–293. doi:10.1016/j.ccr.2010.08.013.
   PubMed Web of Science ®Google Scholar
• Suresh S, McCallum L, Lu W, Lazar N, Perbal B, Irvine AE. MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML. J Cell Commun Signal. 2011;5(3):183–191. doi:10.1007/s12079-011-0139-x.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, Li J, Ji ZL. The role of miR-130a in cancer. Breast Cancer. 2017;24(4):521–527. doi:10.1007/s12282-017-0776-x.
   PubMed Web of Science ®Google Scholar
• Yu XF, Wang J, N OU, Guo S, Sun H, Tong J, Chen T, Li J. The role of miR-130a-3p and SPOCK1 in tobacco exposed bronchial epithelial BEAS-2B transformed cells: comparison to A549 and H1299 lung cancer cell lines. J Toxicol Environ Health A. 2019;82(15):862–869. doi:10.1080/15287394.2019.1664479.
   PubMed Web of Science ®Google Scholar
• Wei H, Cui R, Bahr J, Zanesi N, Luo Z, Meng W, Liang G, Croce CM. miR-130a deregulates PTEN and stimulates tumor growth. Cancer Res. 2017;77(22):6168–6178. doi:10.1158/0008-5472.CAN-17-0530.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu J, Hu L, Kong L, Wang T, Di M, Li C, Gui S. miR-130a alleviates neuronal apoptosis and changes in expression of Bcl-2/Bax and caspase-3 in cerebral infarction rats through PTEN/PI3K/Akt signaling pathway. Exp Ther Med. 2020;19(3):2119–2126. doi:10.3892/etm.2020.8415.
   PubMed Web of Science ®Google Scholar
• Liu HL, Bao HG, Zheng CL, Teng C, Bai MH. MiR-130a regulating the biological function of colon cancer by targeting inhibition of PTEN. Eur Rev Med Pharmacol Sci. 2020;24(4):1786–1793. doi:10.26355/eurrev_202002_20356.
   PubMed Web of Science ®Google Scholar
• Yang L, Li N, Wang H, Jia X, Wang X, Luo J. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol Rep. 2012;28(2):592–600. doi:10.3892/or.2012.1823.
   PubMed Web of Science ®Google Scholar
• Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, Zhang J. Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun. 2012;425(2):468–472. doi:10.1016/j.bbrc.2012.07.127.
   PubMed Web of Science ®Google Scholar
• Eichelmann AK, Matuszcak C, Lindner K, Haier J, Hussey DJ, Hummel R. Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma. Sci Rep. 2018;8(1):17553. doi:10.1038/s41598-018-35799-1.
   PubMed Web of Science ®Google Scholar
• Zheng T, Shi Y, Zhang J, Peng J, Zhang X, Chen K, Chen Y, Liu L. MiR-130a exerts neuroprotective effects against ischemic stroke through PTEN/PI3K/AKT pathway. Biomed Pharmacother. 2019;117:109117. doi:10.1016/j.biopha.2019.109117.
   PubMed Web of Science ®Google Scholar
• Zhang CY, Ren XM, Li HB, Wei W, Wang KX, Li YM, Hu JL, Li X. Effect of miR-130a on neuronal injury in rats with intracranial hemorrhage through PTEN/PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(11):4890–4897. doi:10.26355/eurrev_201906_18077.
   PubMed Web of Science ®Google Scholar
• Luo H, Chen B, Weng B, Tang X, Chen Y, Yang A, Chu D, Zeng X, Ran M. miR-130a promotes immature porcine Sertoli cell growth by activating SMAD5 through the TGF-beta-PI3K/AKT signaling pathway. FASEB J. 2020;34(11):15164–15179. doi:10.1096/fj.202001384R.
   PubMed Web of Science ®Google Scholar
• Pan Y, Wang R, Zhang F, Chen Y, Lv Q, Long G, Yang K. MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A. Int J Clin Exp Pathol. 2015;8:384–393.
   PubMedGoogle Scholar
• Jiang H, Yu WW, Wang LL, Peng Y. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol Rep. 2015;34(3):1153–1161. doi:10.3892/or.2015.4099.
   PubMed Web of Science ®Google Scholar
• Hager M, Pedersen CC, Larsen MT, Andersen MK, Hother C, Gronbaek K, Jarmer H, Borregaard N, Cowland JB. MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-beta1 stimulation in granulocytic precursors. Blood. 2011;118(25):6649–6659. doi:10.1182/blood-2011-03-339978.
   PubMed Web of Science ®Google Scholar
• Ding L, Ni J, Yang F, Huang L, Deng H, Wu Y, Ding X, Tang J. Promising therapeutic role of miR-27b in tumor. Tumour Biol. 2017;39(3):1010428317691657. doi:10.1177/1010428317691657.
   Google Scholar
• Yao J, Deng B, Zheng L, Dou L, Guo Y, Guo K. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition. Oncol Rep. 2016;35(3):1645–1651. doi:10.3892/or.2015.4500.
   PubMed Web of Science ®Google Scholar
• Ye J, Wu X, Wu D, Wu P, Ni C, Zhang Z, Chen Z, Qiu F, Xu J, Huang J. miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer. PLoS One. 2013;8(4):e60687. doi:10.1371/journal.pone.0060687.
   PubMed Web of Science ®Google Scholar
• Melo SA, Kalluri R. Angiogenesis is controlled by miR-27b associated with endothelial tip cells. Blood. 2012;119(11):2439–2440. doi:10.1182/blood-2012-01-403642.
   PubMed Web of Science ®Google Scholar
• Liu J, Sun F, Wang X, Bi Q. miR-27b promotes angiogenesis and skin repair in scalded rats through regulating VEGF-C expression. Lasers Med Sci. 2020;35(7):1577–1588. doi:10.1007/s10103-020-02991-7.
   PubMed Web of Science ®Google Scholar
• Veliceasa D, Biyashev D, Qin G, Misener S, Mackie AR, Kishore R, Volpert OV. Therapeutic manipulation of angiogenesis with miR-27b. Vasc Cell. 2015;7(1):6. doi:10.1186/s13221-015-0031-1.
   PubMedGoogle Scholar
• Sun F, Bi Q, Wang X, Liu J. Down-regulation of mir-27b promotes angiogenesis and fibroblast activation through activating PI3K/AKT signaling pathway. Wound Repair Regen. 2020;28(1):39–48. doi:10.1111/wrr.12765.
   PubMed Web of Science ®Google Scholar
• Yang WH, Chang AC, Wang SW, Wang SJ, Chang YS, Chang TM, Hsu SK, Fong YC, Tang CH. Leptin promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-27b in human chondrosarcoma cells. Sci Rep. 2016;6(1):28647. doi:10.1038/srep28647.
   PubMedGoogle Scholar
• Xia M, Duan LJ, Lu BN, Pang YZ, Pang ZR. LncRNA AFAP1-AS1/miR-27b-3p/VEGF-C axis modulates stemness characteristics in cervical cancer cells. Chin Med J (Engl). 2021;134(17):2091–2101. doi:10.1097/CM9.0000000000001665.
   PubMed Web of Science ®Google Scholar
• Shen S, Sun Q, Liang Z, Cui X, Ren X, Chen H, Zhang X, Zhou Y. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status. PLoS One. 2014;9(6):e100664. doi:10.1371/journal.pone.0100664.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cai Q, Bao PP, Su Y, Cai H, Wu J, Ye F, Guo X, Zheng W, Zheng Y, et al. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes. Breast Cancer Res Treat. 2015;152(1):183–191. doi:10.1007/s10549-015-3460-x.
   PubMed Web of Science ®Google Scholar
• Zhen YB, Guo XL, Xu B, Zhao HW, Xu CJ. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer. Neoplasma. 2016;63(6):856–864. doi:10.4149/neo_2016_604.
   PubMed Web of Science ®Google Scholar
• Wang B, Li D, Filkowski J, Rodriguez-Juarez R, Storozynsky Q, Malach M, Carpenter E, Kovalchuk O. A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382. Oncogenesis. 2018;7(7):54. doi:10.1038/s41389-018-0063-5.
   PubMedGoogle Scholar
• Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 2006;24(4):857–864. doi:10.1634/stemcells.2005-0441.
   PubMed Web of Science ®Google Scholar
• Judson RL, Babiarz JE, Venere M, Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol. 2009;27(5):459–461. doi:10.1038/nbt.1535.
   PubMed Web of Science ®Google Scholar
• Gruber AJ, Grandy WA, Balwierz PJ, Dimitrova YA, Pachkov M, Ciaudo C, Nimwegen E, Zavolan M. Embryonic stem cell-specific microRNAs contribute to pluripotency by inhibiting regulators of multiple differentiation pathways. Nucleic Acids Res. 2014;42(14):9313–9326. doi:10.1093/nar/gku544.
   PubMed Web of Science ®Google Scholar
• Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A, et al. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol. 2011;193(2):409–424. doi:10.1083/jcb.201010100.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang G, Wu JH, Jiang CP. Diverse roles of miR-29 in cancer (review). Oncol Rep. 2014;31(4):1509–1516. doi:10.3892/or.2014.3036.
   PubMed Web of Science ®Google Scholar
• Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, Gammell P, Clynes M, Barron N. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer. 2009;45(17):3104–3118. doi:10.1016/j.ejca.2009.09.014.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. Eur J Cell Biol. 2013;92(3):123–128. doi:10.1016/j.ejcb.2012.11.004.
   PubMed Web of Science ®Google Scholar
• Mott JL, Kobayashi S, Bronk SF, Gores G. J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene. 2007;26(42):6133–6140. doi:10.1038/sj.onc.1210436.
   PubMed Web of Science ®Google Scholar
• Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, et al. MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009;114(26):5331–5341. doi:10.1182/blood-2009-03-211938.
   PubMed Web of Science ®Google Scholar
• Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009;10(4):400–405. doi:10.1038/embor.2009.9.
   PubMed Web of Science ®Google Scholar
• Fan X, Zhou S, Zheng M, Deng X, Yi Y, Huang T. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM). Biomed Pharmacother. 2017;88:507–514. doi:10.1016/j.biopha.2017.01.058.
   PubMed Web of Science ®Google Scholar
• Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell. 2012;151(5):1068–1082. doi:10.1016/j.cell.2012.10.028.
   PubMed Web of Science ®Google Scholar
• Ye H, Pang L, Wu Q, Zhu Y, Guo C, Deng Y, Zheng X. A critical role of mir-199a in the cell biological behaviors of colorectal cancer. Diagn Pathol. 2015;10(1):65. doi:10.1186/s13000-015-0260-x.
   PubMedGoogle Scholar
• Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F, Jiang J, Tang Z. MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling. Dig Dis Sci. 2014;59:2163–2172.
   PubMed Web of Science ®Google Scholar
• Byrnes KA, Phatak P, Mansour D, Xiao L, Zou T, Rao JN, Turner DJ, Wang JY, Donahue JM. Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11). Oncotarget. 2016;7(8):8756–8770. doi:10.18632/oncotarget.6752.
   PubMedGoogle Scholar
• Gherghiceanu M, Popescu LM. Cardiac telocytes - their junctions and functional implications. Cell Tissue Res. 2012;348(2):265–279. doi:10.1007/s00441-012-1333-8.
   PubMed Web of Science ®Google Scholar
• Xiao J, Wang F, Liu Z, Yang C. Telocytes in liver: electron microscopic and immunofluorescent evidence. J Cell Mol Med. 2013;17(12):1537–1542. doi:10.1111/jcmm.12195.
   PubMed Web of Science ®Google Scholar
• Popescu BO, Gherghiceanu M, Kostin S, Ceafalan L, Popescu LM. Telocytes in meninges and choroid plexus. Neurosci Lett. 2012;516(2):265–269. doi:10.1016/j.neulet.2012.04.006.
   PubMed Web of Science ®Google Scholar
• Luesma MJ, Gherghiceanu M, Popescu LM. Telocytes and stem cells in limbus and uvea of mouse eye. J Cell Mol Med. 2013;17(8):1016–1024. doi:10.1111/jcmm.12111.
   PubMed Web of Science ®Google Scholar
• Li L, Lin M, Li L, Wang R, Zhang C, Qi G, Xu M, Rong R, Zhu T. Renal telocytes contribute to the repair of ischemically injured renal tubules. J Cell Mol Med. 2014;18(6):1144–1156. doi:10.1111/jcmm.12274.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Gherghiceanu M, Suciu LC, Manole CG, Hinescu ME. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 2011;345(3):391–403. doi:10.1007/s00441-011-1229-z.
   PubMed Web of Science ®Google Scholar
• Bojin FM, Gavriliuc OI, Cristea MI, Tanasie G, Tatu CS, Panaitescu C, Paunescu V. Telocytes within human skeletal muscle stem cell niche. J Cell Mol Med. 2011;15(10):2269–2272. doi:10.1111/j.1582-4934.2011.01386.x.
   PubMed Web of Science ®Google Scholar
• Bani D, Formigli L, Gherghiceanu M, Faussone-Pellegrini MS. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J Cell Mol Med. 2010;14(10):2531–2538. doi:10.1111/j.1582-4934.2010.01119.x.
   PubMed Web of Science ®Google Scholar
• Popescu LM, Manole E, Serboiu CS, Manole CG, Suciu LC, Gherghiceanu M, Popescu BO. Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration. J Cell Mol Med. 2011;15:1379–1392.
   PubMed Web of Science ®Google Scholar
• Tang XL, Zhang FL, Jiang XJ, Yang XJ. Telocytes enhanced the proliferation, adhesion and motility of endometrial stromal cells as mediated by the ERK pathway in vitro. Am J Transl Res. 2019;11:572–585.
   PubMed Web of Science ®Google Scholar
• Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010;14(4):871–877. doi:10.1111/j.1582-4934.2010.01060.x.
   PubMed Web of Science ®Google Scholar
• Zhao B, Liao Z, Chen S, Yuan Z, Yilin C, Lee KK, Qi X, Shen X, Zheng X, Quinn T, et al. Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats. J Cell Mol Med. 2014;18(5):780–789. doi:10.1111/jcmm.12259.
   PubMed Web of Science ®Google Scholar
• Zhao B, Chen S, Liu J, Yuan Z, Qi X, Qin J, Zheng X, Shen X, Yu Y, Qnin TJ, et al. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J Cell Mol Med. 2013;17(1):123–133. doi:10.1111/j.1582-4934.2012.01655.x.
   PubMed Web of Science ®Google Scholar
• Manole CG, Cismasiu V, Gherghiceanu M, Popescu LM. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med. 2011;15(11):2284–2296. doi:10.1111/j.1582-4934.2011.01449.x.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, Hu G, Sun Y. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. 2015;13(1):45. doi:10.1186/s12916-015-0278-7.
   PubMedGoogle Scholar
• Mou Y, Wang Y, Li J, Lu S, Duan C, Du Z, Yang G, Chen W, Zhao S, Zhou J, et al. Immunohistochemical characterization and functional identification of mammary gland telocytes in the self-assembly of reconstituted breast cancer tissue in vitro. J Cell Mol Med. 2013;17(1):65–75. doi:10.1111/j.1582-4934.2012.01646.x.
   PubMed Web of Science ®Google Scholar
• Aleksandrovych V, Gil K. Telocytes in the tumor microenvironment. Adv Exp Med Biol. 2021;1329:205–216.
   PubMed Web of Science ®Google Scholar
• Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24(1):59–85. doi:10.1093/humupd/dmx032.
   PubMed Web of Science ®Google Scholar
• Mirancea N, Morosanu AM, Mirancea GV, Juravle FD, Manoiu VS. Infrastructure of the telocytes from tumor stroma in the skin basal and squamous cell carcinomas. Rom J Morphol Embryol. 2013;54:1025–1037.
   PubMed Web of Science ®Google Scholar
• Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591–5596. doi:10.1242/jcs.116392.
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Ratajczak D, Pedziwiatr D. Extracellular microvesicles (ExMVs) in cell to cell communication: a role of telocytes. Adv Exp Med Biol. 2016;913:41–49.
   PubMed Web of Science ®Google Scholar
• Diaz-Flores L, Gutierrez R, Gonzalez-Gomez M, Garcia MP, Diaz-Flores L Jr, Carrasco JL, Martin-Vasallo P. CD34+ stromal cells/telocytes as a source of cancer-associated fibroblasts (CAFs) in invasive lobular carcinoma of the breast. Int J Mol Sci. 2021;22(7):3686. doi:10.3390/ijms22073686.
   PubMed Web of Science ®Google Scholar
• Janas P, Kucybala I, Radon-Pokracka M, Huras H. Telocytes in the female reproductive system: an overview of up-to-date knowledge. Adv Clin Exp Med. 2018;27(4):559–565. doi:10.17219/acem/68845.
   PubMed Web of Science ®Google Scholar